基于全方位持续评估的抑郁症优化测量循证照护(OMBC):多中心随机对照临床试验的原理与方案
本研究为在中国8个中心开展的多中心随机对照试验,目标招募900例重性抑郁障碍患者,按2:1随机分配至优化测量循证照护(OMBC)组与常规治疗(TAU)组,急性期12周、维持期12个月,主要结局为急性期完全缓解率和QIDS-SR 16总分≤5的比例,以及维持期复发率/时间。
要点
- 目标招募900例重性抑郁障碍患者,中国8个中心参与,按2:1随机分为MBC组与TAU组。
- 急性期12周主要结局为完全缓解率和QIDS-SR 16总分≤5的患者比例。
- 维持期12个月比较两组复发率及复发时间,次要结局包括QIDS-SR 16、PHQ-9、HAMD-17变化及应答率。
核心结论
- 研究旨在通过建立基于全方位持续评估的抑郁症综合MBC框架,实现MBC的优化(OMBC)。
研究设计与样本
- 多中心随机对照临床试验,在中国8个中心开展,目标招募900例患者,按2:1随机分配至MBC组和TAU组。
局限性
- 试验注册为回顾性注册,于2017年9月4日完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the recent findings presenting the benefits of measurement-based care (MBC) compared to treatment as usual (TAU), MBC is still not the standard of care used in clinical settings. The aim of the present study was to achieve the optimization of MBC (OMBC) for major depressive disorder (MDD) by establishing a comprehensive MBC framework based on all-round, continuous assessment for depression. METHODS: The target recruitment size is 900 patients, and the study is conducted at 8 centers in China. The patients are randomly assigned to the MBC and TAU groups at a 2:1 ratio. The subjects are scheduled to remain for 12 weeks in the acute phase and for 12 months in the maintenance phase. The primary outcomes are the complete remission rate and the proportion of patients with a 16-item Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR 16) total score ≤ 5 of the MBC and TAU groups at the acute phase, and the recurrence rate/time between the two groups is measured at the maintenance phase. Secondary outcomes included the changes in the parameters QIDS-SR 16, Patient Health Questionnaire-9 (PHQ-9), and 17-item Hamilton Rating Scale for Depression (HAMD-17) from baseline and the response rate between the two groups at the acute phase as well as the comparison of recurrence rate between the two groups at the end of the study. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-OOC-17012566 . The registration was performed retrospectively on 4 September 2017.
引用
- Zhou J, Wang X, Yang J, et al. Optimization of measurement-based care (OMBC) for depression based on all-round and continuous assessment: rationale and protocol for a multicenter randomized control clinical trial. Trials. 2022. PMID: 35505437. doi:10.1186/s13063-022-06295-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。